CIBC Asset Management
AKYA

CIBC Asset Management’s Akoya BioSciences AKYA Stock Holding History

CIBC Asset Management’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-115,644
Closed -$564K – 1131
2023
Q4 		$564K Buy
115,644
+73,737
+176% +$306K ﹤0.01% 707
2023
Q3 		$195K Hold
41,907
– – ﹤0.01% 942
2023
Q2 		$310K Sell
41,907
-180,275
-81% -$1.2M ﹤0.01% 809
2023
Q1 		$1.82M Sell
222,182
-31,340
-12% -$327K 0.01% 575
2022
Q4 		$2.43M Hold
253,522
– – 0.01% 498
2022
Q3 		$2.98M Buy
+253,522
New +$3.34M 0.01% 435

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Asset Management's AKYA Position: Q1 2024 in Review

CIBC Asset Management sold out of Akoya BioSciences (AKYA) in Q1 2024, closing a stake of 115,644 shares — an estimated $564K sold.

CIBC Asset Management first reported a position in AKYA in Q3 2022 and held it in 6 quarters. The position peaked at $2.98M in Q3 2022. 68 funds tracked by Wall St. Rank hold AKYA as of Q1 2024.

  • CIBC Asset Management reported no remaining Akoya BioSciences position as of Q1 2024 after selling out during the quarter.
  • CIBC Asset Management sold 115,644 Akoya BioSciences shares in Q1 2024, an estimated $564K.
  • CIBC Asset Management first reported a position in Akoya BioSciences in Q3 2022 and held it in 6 quarters.
  • CIBC Asset Management's Akoya BioSciences position peaked at $2.98M in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Akoya BioSciences as of Q1 2024.

Based on CIBC Asset Management's 13F filing for Q1 2024, filed 9 May 2024.